The CRO for CNS
The only CRO focused exclusively on central nervous system (CNS) drug development, an area of significant unmet need.
Substance Use Disorders
Rare and Ultra-Rare CNS Diseases
Bringing new therapies to patients living with mental health, neurological and substance use disorders.
Experience, Scientific Knowledge and Operational Expertise Combine With Accountability, Responsibility and Integrity
Latest News & Updates
Clinilabs congratulates Larimar Therapeutics Inc. on their Topline Phase 1 Clinical Trial Data in patients with Friedreich’s Ataxia
Clinilabs congratulates Larimar Therapeutics Inc. on their Topline Phase 1 Clinical Trial Data in patients with Friedreich’s Ataxia! We are [...]
2020 will go down as a miserable year, but beyond the heartache, some developments may represent bright spots that light [...]
T3D Therapeutics selects Clinilabs Drug Development Corporation as contract research organization partner for Phase 2 trial of T3D-959 in patients with Alzheimer’s Disease.
T3D Therapeutics, Inc. (“T3D Therapeutics” or the “Company”), a biopharmaceutical company specializing in the development of ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough [...]
Connect With Us
Connect with us online, or come visit us at
an upcoming industry event!
- May 25 @ 7:00 pm - 8:30 pm at Virtual
- June 12 @ 8:00 am - June 16 @ 5:00 pm at Virtual
- September 6 @ 8:00 am - September 8 @ 5:00 pm at Virtual
A PATIENT-CENTRIC APPROACH TO CLINICAL TRIALS
Volunteers & Patients
We empower study participants by educating them about clinical research, enabling them to make informed decisions regarding study participation.
NEW POSSIBILITIES FOR
Clinilabs collaborates with investigator sites worldwide to conduct clinical trials that lead to new drug approvals. Become an investigator in our global network!